UAE's Ministry of Health and Prevention announced the registration of Sinopharm's inactivated virus vaccine BBICP-CorV, after an interim analysis of the Phase III trials showed BBIBP-CorV to have a 86% efficacy against COVID-19 infection.
The Ministry of Health and Prevention announces the registration of Sinopharm's inactivated virus vaccine BBICP-CorV, after an interim analysis of the Phase III trials showed BBIBP-CorV to have an 86% efficacy against COVID-19 infection.
